Meredith Ian T 4

4 · BOSTON SCIENTIFIC CORP · Filed Feb 17, 2022

Form 4

Period: 2022-02-15

EVP/ Global Chief Medical Offi

Transactions

Tax Payment
Common Stock
2022-02-15$44.01/sh−326$14,347→ 31,621 total
Award
Restricted Stock Units
2022-02-16+4,525→ 4,525 total
Exp: 2026-02-16→ Common Stock (4,525 underlying)
Award
Stock Option (Right to Buy)
2022-02-16+12,941→ 12,941 total
Exercise: $44.19Exp: 2032-02-16→ Common Stock (12,941 underlying)
Exercise/Conversion
Common Stock
2022-02-15+1,108→ 31,947 total
Exercise/Conversion
Deferred Stock Units
2022-02-15−1,108→ 1,108 total
Exp: 2023-02-15→ Common Stock (1,108 underlying)

Footnotes (5)

[F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
[F3]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
[F5]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

Documents

1 file